Chrome Extension
WeChat Mini Program
Use on ChatGLM

Scalable querying of human cell atlases via a foundational model reveals commonalities across fibrosis-associated macrophages

Graham Heimberg, Tony Kuo, Daryle DePianto, Tobias Heigl,Nathaniel Diamant, Omar Salem,Gabriele Scalia,Tommaso Biancalani, Jason Rock,Shannon Turley,Héctor Corrada Bravo,Josh Kaminker, Jason A. Vander Heiden, Aviv Regev

bioRxiv (Cold Spring Harbor Laboratory)(2023)

Cited 0|Views2
No score
Abstract
Single-cell RNA-seq (scRNA-seq) studies have profiled over 100 million human cells across diseases, developmental stages, and perturbations to date. A singular view of this vast and growing expression landscape could help reveal novel associations between cell states and diseases, discover cell states in unexpected tissue contexts, and relate in vivo cells to in vitro models. However, these require a common, scalable representation of cell profiles from across the body, a general measure of their similarity, and an efficient way to query these data. Here, we present SCimilarity, a metric learning framework to learn and search a unified and interpretable representation that annotates cell types and instantaneously queries for a cell state across tens of millions of profiles. We demonstrate SCimilarity on a 22.7 million cell corpus assembled across 399 published scRNA-seq studies, showing accurate integration, annotation and querying. We experimentally validated SCimilarity by querying across tissues for a macrophage subset originally identified in interstitial lung disease, and showing that cells with similar profiles are found in other fibrotic diseases, tissues, and a 3D hydrogel system, which we then repurposed to yield this cell state in vitro . SCimilarity serves as a foundational model for single cell gene expression data and enables researchers to query for similar cellular states across the entire human body, providing a powerful tool for generating novel biological insights from the growing Human Cell Atlas. ### Competing Interest Statement All authors are employees of Genentech or Roche. A.R. is a co-founder and equity holder of Celsius Therapeutics, an equity holder in Immunitas, and until July 31, 2020 was an S.A.B. member of Thermo Fisher Scientific, Syros Pharmaceuticals, Neogene Therapeutics and Asimov.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined